Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Fuentes Julián, Sherezade ^a   Arnalich Montiel, Francisco ^b   Jaumandreu, Laia ^b   Leal, Marina ^b   Casado, Alfonso ^b   García Tuñon, Ignacio ^a   Hernández Jiménez, Enrique ^c   López Collazo, Eduardo ^c   De Miguel, Maria P ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; THY 1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL VACUOLE; CHONDROGENESIS; COCULTURE; CONTROLLED STUDY; CORNEA EDEMA; CORNEA NEOVASCULARIZATION; CORNEA THICKNESS; CORNEA TRANSPLANTATION; CULTURE MEDIUM; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; IN VITRO STUDY; INNATE IMMUNITY; LIPOSUCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; RABBIT; SLIT LAMP; STROMA CELL; SURGICAL TECHNIQUE; ADIPOSE TISSUE; ALLOTRANSPLANTATION; ANIMAL; CORNEA; CORNEAL DISEASES; CYTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE; XENOGRAFT;

MURINAE; ORYCTOLAGUS CUNICULUS;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CORNEA; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; CYTOKINES; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RABBITS; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84923823609     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117945     Document Type: Article

References (57)

1. Chong EM, Dana MR (2008) Graft failure IV. Immunologic mechanisms of corneal transplant rejection. International ophthalmology 28: 209-222. PMID: 17673946
2. (2009) Eye Banking Statistical Report. Eye bank asociation of America.
3. Thompson RW Jr, Price MO, Bowers PJ, Price FW Jr (2003) Long-term graft survival after penetrating keratoplasty. Ophthalmology 110: 1396-1402. PMID: 12867398
4. (2012) The Australian Corneal Graft Registry.
5. Niederkorn JY, Larkin DF (2010) Immune privilege of corneal allografts. Ocular immunology and inflammation 18: 162-171. doi: 10.3109/09273948.2010.486100 PMID: 20482389
6. Birnbaum F, Mayweg S, Reis A, Bohringer D, Seitz B, et al. (2009) Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study. Eye 23: 2063-2070. doi: 10.1038/eye.2008.402 PMID: 19151659
7. Birnbaum F, Bohringer D, Sokolovska Y, Sundmacher R, Reinhard T (2005) Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study. Transplantation 79: 964-968. PMID: 15849551
8. De Miguel MP, Fuentes-Julian S, Blazquez-Martinez A, Pascual CY, Aller MA, et al. (2012) Immunosuppressive properties of mesenchymal stem cells: advances and applications. Current molecular medicine 12: 574-591. PMID: 22515979
9. Oh JY, Lee RH, Yu JM, Ko JH, Lee HJ, et al. (2012) Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response. Mol Ther 20: 2143-2152. doi: 10.1038/mt.2012.165 PMID: 22929658
10. Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, et al. (2006) Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81: 1589-1595. PMID: 16770249
11. Seifert M, Stolk M, Polenz D, Volk HD (2012) Detrimental effects of rat mesenchymal stromal cell pretreatment in a model of acute kidney rejection. Frontiers in immunology 3: 202. doi: 10.3389/fimmu. 2012.00202 PMID: 22826709
12. Hauner H, Loffler G (1987) Adipose tissue development: the role of precursor cells and adipogenic factors. Part I: A dipose tissue development and the role of precursor cells. Klin Wochenschr 65: 803-811. PMID: 3309456
13. Katz AJ, Llull R, Hedrick MH, Futrell JW (1999) Emerging approaches to the tissue engineering of fat. Clin Plast Surg 26: 587-603, viii. PMID: 10553215
14. Arnalich-Montiel F, Pastor S, Blazquez-Martinez A, Fernandez-Delgado J, Nistal M, et al. (2008) Adi-pose- derived stem cells are a source for cell therapy of the corneal stroma. Stem Cells 26: 570-579. PMID: 18065394
15. Im GI, Shin YW, Lee KB (2005) Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage 13: 845-853. PMID: 16129630
16. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228. PMID: 11304456
17. Lin Y, Chen X, Yan Z, Liu L, Tang W, et al. (2006) Multilineage differentiation of adipose-derived stromal cells from GFP transgenic mice. Mol Cell Biochem 285: 69-78. PMID: 16477377
18. Shi W, Gao H, Xie L, Wang S (2006) Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits. Invest Ophthalmol Vis Sci 47: 3339-3344. PMID: 16877400
19. Ren G, Su J, Zhang L, Zhao X, Ling W, et al. (2009) Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27: 1954-1962. doi: 10.1002/stem.118 PMID: 19544427
20. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, et al. (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2: 141-150. doi: 10.1016/j.stem.2007.11.014 PMID: 18371435
21. Xu G, Zhang Y, Zhang L, Roberts AI, Shi Y (2009) C/EBPbeta mediates synergistic upregulation of gene expression by interferon-gamma and tumor necrosis factor-alpha in bone marrow-derived mesenchymal stem cells. Stem Cells 27: 942-948. doi: 10.1002/stem.22 PMID: 19353522
22. Menard C, Pacelli L, Bassi G, Dulong J, Bifari F, et al. (2013) Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls. Stem Cells Dev 22: 1789-1801. doi: 10.1089/scd. 2012.0594 PMID: 23339531
23. Rathmell JC, Vander Heiden MG, Harris MH, Frauwirth KA, Thompson CB (2000) In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol Cell 6: 683-692. PMID: 11030347
24. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, et al. (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30: 42-48. PMID: 11823036
25. Casiraghi F, Azzollini N, Cassis P, Imberti B, Morigi M, et al. (2008) Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 181: 3933-3946. PMID: 18768848
26. Ding Y, Xu D, Feng G, Bushell A, Muschel RJ, et al. (2009) Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and-9. Diabetes 58: 1797-1806. doi: 10.2337/db09-0317 PMID: 19509016
27. Zhang W, Qin C, Zhou ZM (2007) Mesenchymal stem cells modulate immune responses combined with cyclosporine in a rat renal transplantation model. Transplant Proc 39: 3404-3408. PMID: 18089393
28. Crop MJ, Korevaar SS, de Kuiper R, JN IJ, van Besouw NM, et al. (2011) Human mesenchymal stem cells are susceptible to lysis by CD8(+) T cells and NK cells. Cell Transplant 20: 1547-1559. doi: 10. 3727/096368910X564076 PMID: 21396164
29. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, et al. (2006) Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108: 2114-2120. PMID: 16690970
30. Nie C, Yang D, Xu J, Si Z, Jin X, et al. (2011) Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant 20: 205-216. doi: 10. 3727/096368910X520065 PMID: 20719083
31. Rigol M, Solanes N, Roura S, Roque M, Novensa L, et al. (2014) Allogeneic adipose stem cell therapy in acute myocardial infarction. Eur J Clin Invest 44: 83-92. doi: 10.1111/eci.12195 PMID: 24350923
32. Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, et al. (2008) A critical role of IFNgamma in priming MSCmediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res 18: 846-857. doi: 10.1038/cr.2008.80 PMID: 18607390
33. Hemeda H, Jakob M, Ludwig AK, Giebel B, Lang S, et al. (2010) Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev 19: 693-706. doi: 10.1089/scd.2009.0365 PMID: 20067407
34. Bernardo ME, Fibbe WE (2013) Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13: 392-402. doi: 10.1016/j.stem.2013.09.006 PMID: 24094322
35. Chan JL, Tang KC, Patel AP, Bonilla LM, Pierobon N, et al. (2006) Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 107: 4817-4824. PMID: 16493000
36. Stagg J, Pommey S, Eliopoulos N, Galipeau J (2006) Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood 107: 2570-2577. PMID: 16293599
37. Francois M, Romieu-Mourez R, Stock-Martineau S, Boivin MN, Bramson JL, et al. (2009) Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties. Blood 114: 2632-2638. doi: 10.1182/blood-2009-02-207795 PMID: 19654411
38. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31: 890-896. PMID: 14550804
39. Lee RH, Yu JM, Foskett AM, Peltier G, Reneau JC, et al. (2014) TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo. Proc Natl Acad Sci USA.
40. Jia Z, Jiao C, Zhao S, Li X, Ren X, et al. (2012) Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model. Exp Eye Res 102: 44-49. doi: 10.1016/j.exer.2012.06.008 PMID: 22800963
41. Engela AU, Baan CC, Peeters AM, Weimar W, Hoogduijn MJ (2013) Interaction between adipose tissue- derived mesenchymal stem cells and regulatory T-cells. Cell Transplant 22: 41- 54. doi: 10.3727/ 096368912X636984 PMID: 22472599
42. Kuo YR, Chen CC, Goto S, Lee IT, Huang CW, et al. (2011) Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model. Plast Reconstr Surg 128: 661e-672e. doi: 10.1097/PRS.0b013e318230c60b PMID: 22094768
43. Ohmura Y, Tanemura M, Kawaguchi N, Machida T, Tanida T, et al. (2010) Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice. Transplantation 90: 1366-1373. doi: 10.1097/TP.0b013e3181ffba31 PMID: 21076379
44. Fang B, Song Y, Lin Q, Zhang Y, Cao Y, et al. (2007) Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children. Pediatr Transplant 11: 814-817. PMID: 17910665
45. Seifert M, Stolk M, Polenz D, Volk HD (2012) Detrimental effects of rat mesenchymal stromal cell pretreatment in a model of acute kidney rejection. Front Immunol 3: 202. doi: 10.3389/fimmu.2012.00202 PMID: 22826709
46. Ge W, Jiang J, Baroja ML, Arp J, Zassoko R, et al. (2009) Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant 9: 1760-1772. doi: 10.1111/j.1600-6143.2009.02721.x PMID: 19563344
47. Kim YH, Wee YM, Choi MY, Lim DG, Kim SC, et al. (2011) Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts. Mol Med 17: 697-708. doi: 10.2119/molmed.2010.00098 PMID: 21365122
48. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, et al. (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81: 1390-1397. PMID: 16732175
49. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, et al. (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371: 1579-1586. doi: 10.1016/S0140-6736(08)60690-X PMID: 18468541
50. Prasad VK, Lucas KG, Kleiner GI, Talano JA, Jacobsohn D, et al. (2011) Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transplant 17: 534-541. doi: 10.1016/j.bbmt.2010.04.014 PMID: 20457269
51. Zangi L, Margalit R, Reich-Zeliger S, Bachar-Lustig E, Beilhack A, et al. (2009) Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells 27: 2865-2874. doi: 10.1002/stem.217 PMID: 19750539
52. Oh JY, Kim MK, Ko JH, Lee HJ, Lee JH, et al. (2009) Rat allogeneic mesenchymal stem cells did not prolong the survival of corneal xenograft in a pig-to-rat model. Vet Ophthalmol 12 Suppl 1: 35-40. doi: 10.1111/j.1463-5224.2009.00724.x PMID: 19891650
53. Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, et al. (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105: 4120-4126. PMID: 15692068
54. Li YP, Paczesny S, Lauret E, Poirault S, Bordigoni P, et al. (2008) Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol 180: 1598-1608. PMID: 18209056
55. Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L (2009) MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113: 6576-6583. doi: 10.1182/blood-2009-02-203943 PMID: 19398717
56. Ge W, Jiang J, Arp J, Liu W, Garcia B, et al. (2010) Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation 90: 1312-1320. doi: 10.1097/TP.0b013e3181fed001 PMID: 21042238
57. Tavandzi U, Prochazka R, Usvald D, Hlucilova J, Vitaskova M, et al. (2007) A new model of corneal transplantation in the miniature pig: efficacy of immunosuppressive treatment. Transplantation 83: 1401-1403. PMID: 17519795